Glycans are responsible for much of the structural variation in biologic systems, and their representation on cell surfaces is commonly called the “glycome.” Glycomics is an emerging field that aims to focus on the structure and function of glycans in a cell, tissue, or organism. Glycans are the chain-like structures of carbohydrates that are free or conjugated to macromolecules such as lipids or proteins. They contribute to a diverse selection of biological processes such as protein folding, cell signaling, and immune recognition. These are implicated in several diseases such as oncological, autoimmune, and others.
Merck KGaA & Thermo Fisher Scientific Inc.–are Notable Market Players in Glycomics Market
Market Dynamics
The growth of the market is defined by the key driving factors such as increased glycomics research and expanding R&D investments and rising use of glycomics in various diseases leading to the development of new treatment processes. Additionally, the new tools in glycomics research are likely to emerge as a significant future trend in the market during the forecast period. However, the high cost of equipment and shortage of skilled professionals required for glycomics is likely to hinder the growth of the market during the forecast period.
Competitive Landscape
Market leaders operating in the Glycomics market have undertaken various organic and inorganic growth strategies. The Glycomics market majorly consists of players such as Merck KGaA; Agilent Technologies, Inc.; New England Biolabs; Thermo Fisher Scientific Inc.; Waters Corporation; Asparia Glycomics; Bruker Corporation; Takara Bio Inc.; S-BIO; and Shimadzu Corporation and others
Several organic approaches, such as product launches, and expansion in the Glycomics market, have resulted in the growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the company to strengthen its revenue, which allows the company to hold a strong position in the market.
Below is the list of the growth strategies done by the players operating in the Glycomics market:
| Year | News |
| November-2021 | Thermo Fisher Scientific has launched its new mass spectrometry (MS) instruments, workflows, and software, which the company showcased at the 69th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, held in 2021. The Thermo Scientific new system simplifies the transition of biotherapeutics from development to manufacturing and accelerates the biopharma pipeline. |
| June-2020 | Agilent Technologies Inc. introduced two new mass spectrometry (MS) products: the Agilent 6470B Triple Quadrupole LC/MS (6470 LC/TQ) system, and the Agilent RapidFire 400 system. Both deliver even faster detection of target compounds providing customers increased sample throughput and reduced time to generate results. |
| June-2019 | New England Biolabs, Genos, and Waters Corporation collaborated to accelerate glycomics research by providing goods and services critical to glycan analysis. The human glycome project was boosted by the support of critical goods and services from these companies. Launched in October 2018, the Human Glycome Project is a global initiative to map the structure and function of human glycans. |
